Ajay Kumar Danga | Long non-coding RNA | Best Researcher Award

Published on by Molecular Biologist

Dr . Ajay Kumar Danga | Long non-coding RNA | Best Researcher Award 

DBT-RA , National Institute of Immunology , India

Ajay Kumar Danga is a dedicated researcher specializing in the molecular biology of aging and maturation, with a focus on long noncoding RNAs (lncRNAs) in rat testes. His work at Jawaharlal Nehru University (JNU), New Delhi, has contributed significantly to understanding gene regulation during aging. Ajay has been recognized for his academic excellence and contributions to the field of life sciences.

Profile

Scopus

Strengths for the Award

  1. Academic Excellence: Ajay Kumar Danga has consistently demonstrated academic excellence, as evidenced by his silver medal in B.Sc. Zoology (H) and his AIR 1 ranking in the JNU Entrance Exam for PhD in Life Sciences. He has also secured multiple competitive fellowships, such as the ICMR-JRF/SRF and CSIR-NET-JRF.
  2. Research Contributions: His research on the maturation and aging processes in rat testes, particularly focusing on long noncoding RNAs (lncRNAs), is cutting-edge. The work involves complex molecular biology techniques and contributes to understanding the regulatory mechanisms of gene expression in aging.
  3. Technical Proficiency: Ajay has a wide array of specialized laboratory skills, including molecular cloning, RNA-FISH, and genomic DNA methylation analysis. His ability to perform and teach these techniques, along with his experience in bioinformatics tools, highlights his technical expertise.
  4. Recognition and Awards: Ajay’s work has been recognized through several awards, such as the Best Poster Award at Biosparks 2018 and multiple conference presentations at both national and international levels. His ability to consistently produce high-quality research output and gain recognition for it is a testament to his research capabilities.
  5. Collaboration and Leadership: He has collaborated with scientists from industry and academia, demonstrating his ability to work in interdisciplinary teams. Additionally, his role in supervising and mentoring students shows his leadership skills in a research setting.

Areas of Improvement 

  1. Broader Impact of Research: While Ajay’s research is highly specialized and of significant academic interest, its broader implications for public health or clinical applications are not immediately clear. Enhancing the translational impact of his research could strengthen his candidacy for awards that prioritize societal impact.
  2. Publication Record: Although Ajay has made significant contributions to conferences, there is limited information provided about his publication record in peer-reviewed journals. Increasing his number of high-impact journal publications would further solidify his standing as a top researcher.
  3. Diversity of Research Topics: His research is primarily focused on aging and molecular biology. Expanding his research portfolio to include more diverse topics within life sciences could make him a more versatile candidate for various research awards.

    Education 

    Ajay completed his M.Sc. in Medical Biotechnology from Maharshi Dayanand University (MDU), Rohtak, Haryana, India, where he studied the genotoxic effects of Malathion and the potential protective role of Rosemary oil. Prior to that, he earned his B.Sc. in Zoology (Hons) from Dyal Singh College, University of Delhi (DU), New Delhi. Ajay is currently pursuing advanced research at JNU, furthering his exploration into molecular mechanisms in life sciences.

    Experience 

    Ajay’s research journey includes a significant tenure as a Senior Research Fellow (SRF) at JNU, where he delved into the expression of lncRNAs during the aging process in rat testes. He has also served as a Research Associate at the National Institute of Immunology (NII). His experience extends to teaching and guiding M.Sc. and Ph.D. students in molecular biology, ensuring the next generation of scientists are well-prepared for their careers.

    Research Interests 

    Ajay’s research primarily focuses on the role of long noncoding RNAs in the maturation and aging of reproductive tissues. His work involves studying gene expression, cellular changes, and DNA methylation patterns, particularly in the context of aging. Ajay is passionate about uncovering the molecular underpinnings of age-related changes and their implications for human health.

    Awards 

    Ajay has received numerous accolades, including the Silver Medal in his B.Sc. Zoology (Hons) from the University of Delhi, and several prestigious fellowships like the Jawaharlal Nehru University Combined Entrance Examination for Biotechnology (JNU CEEB) and the Indian Council of Medical Research (ICMR) Junior and Senior Research Fellowships. He also achieved the All India Rank 1 in the JNU Entrance Exam for Ph.D. in Life Sciences.

    Publications 

    Ajay has contributed to several research articles and conference papers. Some of his notable publications include:

    1. Expression and localization of LINC-RSAS lncRNA in the rat testes during aging – Poster Presentation, International Conference, Vistas in Life Sciences 2024, JNU.
    2. Expression and localization of LINC-RBE and LINC-RSAS in the rat testes during aging – Poster Presentation, 18th IUIS International Congress of Immunology 2023, Cape Town, South Africa.
    3. Age-related expression and localization of long noncoding RNAs in rat testis – National Science Day, JNU, New Delhi, 2022.

      Conclusion

      Ajay Kumar Danga is a strong candidate for the Best Researcher Award, given his outstanding academic record, technical proficiency, and research contributions. His work on lncRNAs in aging is innovative and has the potential to advance our understanding of aging processes. However, to further enhance his candidacy, he could focus on broadening the impact of his research, increasing his publication output, and diversifying his research topics. Overall, Ajay is a promising researcher whose work is already making significant contributions to the field of life sciences.

Partha Sarathi Nial | B-Z DNA transition | Best Researcher Award

Published on by Molecular Biologist

Mr . Partha Sarathi Nial | B-Z DNA transition | Best Researcher Award 

PhD Scholar , CSIR-Institute of Minerals and Materials Technology , India

Partha Sarathi Nial is a dedicated Ph.D. scholar in Biological Science at the CSIR-Institute of Minerals and Materials Technology, Bhubaneswar, India. His research focuses on DNA nanotechnology, specifically on sequence-specific conformational switching in linear and branched DNA structures. With a strong foundation in biotechnology and extensive experience in both academic research and industry, Partha is committed to advancing our understanding of DNA’s structural dynamics and their potential applications in gene regulation and therapeutics.

Profile

Scopus

Strengths for the Award

  1. Advanced Research Focus: Partha Sarathi Nial’s doctoral research on “Sequence-specific conformational switching in linear and branched DNA structures” showcases a high level of expertise in a cutting-edge area of biological science, particularly in DNA nanotechnology and its applications in gene regulation and therapeutic approaches. His focus on B-Z DNA transition and G-Quadruplex formation is not only innovative but also highly relevant to understanding complex biological processes and diseases like cancer and Alzheimer’s.
  2. Publications in High-Impact Journals: Partha has multiple publications in reputed journals with high impact factors, including the Journal of Molecular Liquids and the International Journal of Biological Macromolecules. These publications underline the quality and impact of his research work in the scientific community.
  3. Awards and Recognitions: Partha’s achievements, such as securing the CSIR-NET JRF (AIR-100) in Life Sciences, demonstrate his strong academic foundation and recognition by peers. Being selected for positions in prestigious organizations like Thyrocare Technologies Ltd. further attests to his credibility and potential.
  4. Research Versatility: Partha’s diverse research experience, ranging from clinical research coordination to plant tissue culture and drug analysis, shows his adaptability and broad expertise in various domains of biological science.
  5. Professional Development: Participation in numerous seminars, workshops, and webinars, including poster presentations at international conferences, reflects his commitment to continuous learning and dissemination of knowledge.

Areas of Improvement

  1. Practical Application Focus: While Partha’s research is highly theoretical and advanced, greater emphasis on practical applications and translational research might further strengthen his candidacy. This could involve exploring more collaborative projects with industry or interdisciplinary teams to apply his findings in real-world scenarios.
  2. Leadership and Collaboration: Although Partha has demonstrated strong research capabilities, leadership roles in collaborative research projects or mentoring junior researchers could enhance his profile. Active involvement in large-scale, multi-disciplinary projects might also broaden his impact.
  3. Broader Impact: Expanding the outreach and societal impact of his research beyond the academic community could be beneficial. Engaging in public science communication, community outreach, or contributing to policy discussions on health and biotechnology could elevate his profile.

     Education

    Partha Sarathi Nial’s academic journey is marked by consistent excellence in the field of biological sciences. He earned his Ph.D. in Biological Science from the CSIR-Institute of Minerals and Materials Technology, focusing on the intricate mechanisms of B-Z DNA transition and its implications in various human diseases. Before his doctoral studies, he completed his B.Ed. in Biological Science from Andhra University and both his M.Sc. and B.Sc. in Biotechnology from Ravenshaw University and Utkal University, respectively, graduating with first-division honors.

     Research Experience

    Partha’s research expertise is deeply rooted in the molecular dynamics of DNA structures. His doctoral research explores the B-Z DNA transition, G-Quadruplex formation, and the impact of Rare Earth Elements on DNA conformations. He has also contributed to projects on gene regulation, therapeutic applications, and DNA nanostructure assembly. His M.Sc. dissertation focused on the micropropagation of Uraria picta, and he has gained hands-on experience in biochemical and bacteriological analysis of dairy products, clinical research on diarrhea, and drug quality evaluation.

     Research Interests

    Partha’s research interests lie at the intersection of molecular biology, nanotechnology, and structural biophysics. He is particularly fascinated by the conformational switching of DNA structures, such as B-Z DNA transitions and G-quadruplex formations, which have significant implications in gene function regulation and nanotechnological applications. His work aims to uncover the underlying mechanisms of these transitions and explore their potential in medical and therapeutic innovations.

     Awards and Achievements

    Partha’s academic and research endeavors have been recognized with several prestigious awards. He secured the Junior Research Fellowship (CSIR-NET JRF) with an impressive All India Rank of 100 in Life Sciences in 2018. Additionally, he was selected as a Clinical Research Coordinator by Consortium Clinical Research Pvt Ltd. and as an Executive in Business Development by Thyrocare Technologies Ltd., showcasing his versatile expertise in both research and industry.

     Publications

    Partha Sarathi Nial has contributed to several high-impact publications in reputable scientific journals. Here are some of his key works:

    1. Nial, P. S., Sathyaseelan, C., Bhanjadeo, M. M., Tulsiyan, K. D., Rathinavelan, T., & Subudhi, U. (2024). Praseodymium chloride-mediated B-to-Z DNA transition in pyrimidine-purine repeat sequences: Simulation and biophysical study. Journal of Molecular Liquids, 125173. Link. Cited by: 5 articles.
    2. Nial, P. S., & Subudhi, U. (2024). Zeta potential of Z-DNA: A new signature to study BZ transition in linear and branched DNA. International Journal of Biological Macromolecules, 266, 131238. Link. Cited by: 3 articles.
    3. Satapathy, S. N., Nial, P. S., Tulsiyan, K. D., & Subudhi, U. (2024). Light rare earth elements stabilize G-quadruplex structure in variants of human telomeric sequences. International Journal of Biological Macromolecules, 254, 127703. Link. Cited by: 4 articles.
    4. Monalisa, K., Behera, S., Pidika, S. P., Nial, P. S., & Naik, S. K. (2024). In vitro propagation and assessment of genetic fidelity of Blepharispermum subsessile DC.: An endangered medicinal plant of India. Vegetos, 1-10. Link. Cited by: 2 articles.
    5. Baral, B., Nial, P. S., & Subudhi, U. (2023). Enhanced enzymatic activity and conformational stability of catalase in presence of tetrahedral DNA nanostructures: A biophysical and kinetic study. International Journal of Biological Macromolecules, 242, 124677. Link. Cited by: 6 articles.
    6. Gourai, M., Nayak, A. K., Nial, P. S., Satpathy, B., Bhuyan, R., Singh, S. K., & Subudhi, U. (2023). Thermal plasma processing of Moringa oleifera biochars: Adsorbents for fluoride removal from water. RSC Advances, 13(7), 4340-4350. Link. Cited by: 7 articles.
    7. Bhanjadeo, M. M., Nial, P. S., Sathyaseelan, C., Singh, A. K., Dutta, J., Rathinavelan, T., & Subudhi, U. (2022). Biophysical interaction between lanthanum chloride and (CG) n or (GC) n repeats: A reversible B-to-Z DNA transition. International Journal of Biological Macromolecules, 216, 698-709. Link. Cited by: 9 articles

    Conclusion

    Partha Sarathi Nial is a highly deserving candidate for the Research for Best Researcher Award. His strong research background in DNA nanotechnology, coupled with significant publications and recognitions, makes him a standout candidate. To further enhance his profile, focusing on practical applications, taking on leadership roles in collaborative research, and broadening the societal impact of his work are recommended. Overall, his current achievements and potential for future contributions to science make him a suitable and strong contender for the award.

Nathalie Yepes | Pediatric | Best Researcher Award

Published on by Molecular Biologist

Dr . Nathalie Yepes | Pediatric | Best Researcher Award 

Residente , Universidad Libre, Seccional Cali , Colombia

Nathalie Yepes is a dedicated pediatric resident currently training at Universidad Libre in Cali, Colombia. With a strong foundation in medicine from Pontificia Universidad Javeriana, she has a keen interest in pediatric care and medical research. Her clinical experience spans across renowned institutions, including Boston Children’s Hospital, where she is part of the Reckitt Pediatric Residents Digital Program.

Profile

ORCiD

Strengths for the Award

  1. Extensive Research Experience: Nathalie has an impressive array of research experiences across various fields of pediatric medicine, including pediatric oncology, infectious diseases, and genetic disorders. Her involvement in high-impact research projects, such as those related to genetic variants in epilepsy and intellectual disability, as well as Behçet’s disease, showcases her commitment to advancing pediatric care through research.
  2. Published Works and Presentations: Nathalie has a robust record of publications in reputable journals, including case reports, systematic reviews, and original research articles. Her work has been presented at prestigious international conferences, such as the European Academy of Paediatric Societies and the World Society for Pediatric Infectious Diseases. This demonstrates her ability to contribute to and disseminate important findings in the global pediatric community.
  3. Leadership and Collaboration: Nathalie has held leadership positions in research groups, such as being the President and Co-Founder of ISSEM PUJ Cali. This indicates her ability to lead collaborative efforts in research, which is crucial for impactful and innovative scientific contributions.
  4. Academic Excellence: Her strong academic background, including a high GPA in medical school and ongoing pediatric residency, provides a solid foundation for her research endeavors. This academic rigor is reflected in the quality and depth of her research outputs.

Areas for Improvement

  1. Focus on Specific Research Themes: While Nathalie has a diverse research portfolio, concentrating on a few core areas could further enhance her expertise and impact. A more focused research agenda could lead to deeper insights and more significant contributions in a particular field.
  2. Broader Impact and Application: Nathalie could work on translating her research findings into clinical practice or policy, ensuring that her work has a tangible impact on pediatric health outcomes. Engaging in interdisciplinary collaborations and outreach could help bridge the gap between research and practice.
  3. Mentorship and Teaching: In addition to her research activities, Nathalie could expand her influence by mentoring younger researchers and contributing to the education of future pediatricians and scientists. This would enhance her profile as a researcher who not only produces high-quality work but also nurtures the next generation of medical professionals.

    Education 

    Nathalie began her academic journey at Philadelphia International School, Cali, and later graduated from Pontificia Universidad Javeriana with a degree in Medicine, earning a commendable GPA of 4.10. She is currently pursuing her Pediatric Residency at Universidad Libre, Cali, with an expected completion in 2025.

    Experience 

    Nathalie’s clinical experience is diverse and rich. She is currently engaged in pediatric rotations at Fundación Clínica Infantil Club Noel, covering areas like pediatric nephrology, pulmonology, and infectious diseases. Additionally, she has presented her research at several seminars and conferences, including the second Seminar on Pediatric Respiratory Therapy.

    Research Interest 

    Nathalie is deeply interested in pediatric research, particularly in genetic disorders and systemic diseases in children. Her ongoing research includes studies on genetic variants associated with epilepsy, polymalformation syndrome, and the role of genomics in pediatric immunology.

    Awards 

    Throughout her career, Nathalie has been recognized for her contributions to research and medicine. She has been a speaker at multiple prestigious conferences and was the President and Co-Founder of the research group ISSEM PUJ during her time at Pontificia Universidad Javeriana.

    Publications 

    1. Behçet’s disease in pediatrics, a diagnostic challenge: Qualitative systematic review of the literature
      Revista Colombiana de Reumatología, 2024
      Read more
      Cited by: Various articles in pediatric rheumatology.
    2. Left Knee Septic Monoarthritis in a Pediatric Patient due to Shewanella putrefaciens: Case Report and Literature Review
      Ann Clin Microbiol Antimicrob, 2024
      Read more
      Cited by: Recent studies on pediatric infections.
    3. Genomics role at the identification of patients with inborn errors of immunity
      Journal of Genetic Engineering and Biotechnology, 2024
      Read more
      Cited by: Research on genetic engineering and pediatric immunology.
    4. Role of gene interactions in the Pathophysiology of skeletal dysplasias: A case report
      Salutem Scientia Spiritus, 2023
      Read more
      Cited by: Articles focusing on skeletal dysplasias in pediatrics.
    5. Crohn’s disease with extensive involvement and unusual extradigestive manifestations: a case report
      Rev Colomb Gastroenterol, 2021
      Read more
      Cited by: Gastroenterology reviews on Crohn’s disease.
    6. Characteristics of the search and identification of scientific articles for systematic reviews in health sciences
      Salutem Scientia Spiritus, 2019
      Read more
      Cited by: Methodological papers on systematic reviews.
    7. Cardiogénesis: Bases estructurales y moleculares a partir del modelo de rata Wistar
      Salutem Scientia Spiritus, 2017
      Read more
      Cited by: Research on cardiogenesis and molecular biology.
    8. Análisis bibliométrico de las publicaciones sobre síndrome metabólico en dos revistas biomédicas colombianas de alto impacto
      Salutem Scientia Spiritus, 2016
      Read more
      Cited by: Bibliometric studies in health sciences.

      Conclusion

      Nathalie Yepes is a highly qualified candidate for the Best Researcher Award. Her extensive research experience, leadership in collaborative projects, and strong academic background make her a strong contender. To further strengthen her candidacy, focusing on specific research themes, ensuring the broader application of her research, and expanding her role in mentorship could be beneficial. Overall, her contributions to pediatric research are significant, and she demonstrates great potential for continued impact in the field.

Thomas Liehr | Human Genetics | Best Researcher Award

Published on by Molecular Biologist

Prof Dr . Thomas Liehr | Human Genetics | Best Researcher Award 

Mr. Institute of Human Genetics at the University Hospital Jena , Germany

Prof. Dr. Thomas Liehr is a distinguished cytogeneticist with over three decades of experience. Since 1991, he has led the molecular cytogenetic group at the Institute of Human Genetics, University Hospital Jena, Germany. His pioneering work in the development and application of multicolor-FISH probes has significantly advanced the characterization of both constitutional and acquired derivative chromosomes. With over 870 research papers, 120 book chapters, and 20 books, Prof. Liehr has made substantial contributions to the field of cytogenetics. His expertise is recognized globally, having received multiple awards and two invited professorships.

Profile

Scopus

Strengths for the Award

  1. Extensive Research Output: Thomas Liehr has an impressive research portfolio with over 870 referred papers, more than 900 abstracts, and contributions to 20 books and 120 book chapters. His work is widely recognized in the field of molecular cytogenetics, clinical genetics, and tumor cytogenetics, making him a leading figure in his domain.
  2. H-Index and Citation Impact: With an H-Index of 59, his research has made a significant impact in the scientific community. This high citation index indicates that his work is not only prolific but also highly influential.
  3. Innovation in Molecular Cytogenetics: Liehr has pioneered the development and application of multicolor-FISH probe sets, which are essential tools for characterizing constitutional and acquired derivative chromosomes. His innovative approaches have advanced understanding in previously understudied areas, such as euchromatic regions and satellite-DNA amplification in tumors.
  4. Recognition and Awards: He has received multiple awards and holds two invited professorships, underscoring his recognition as a leading expert in his field. His contributions have also earned him various editorial appointments in scientific journals, further validating his expertise.
  5. Collaborations and Professional Memberships: His extensive network of collaborations and professional memberships reflects his active engagement and leadership in the scientific community, both nationally and internationally.

Areas of Improvement

  1. Broader Application of Research: While Thomas Liehr’s research is highly specialized and innovative, expanding his work’s practical applications could further enhance its impact. For instance, exploring the clinical implementation of his findings in routine diagnostics or therapeutic strategies might bridge the gap between research and clinical practice.
  2. Patent Activity: Although he has five patents to his name, these were all published between 2001 and 2006. Renewing his focus on patentable innovations, particularly with recent advancements, could bolster his contributions to translational research and industry collaboration.
  3. Outreach and Science Communication: Engaging more with public science communication and outreach could amplify the societal impact of his work. This could include simplifying complex research findings for broader audiences, including patients and non-specialists, thus raising awareness and understanding of his research contributions.

    Education 

    Prof. Dr. Thomas Liehr earned his “Dr. rer. nat.” in genetics, followed by his “med. habil.” and honorary doctorate (h.c.) from Yerevan State University (YSU). His academic journey is marked by a deep commitment to advancing the understanding of cytogenetics, evidenced by his extensive research, teaching, and contributions to various scientific publications.

    Experience 

    Prof. Liehr’s professional career is rooted in his role as the head of the molecular cytogenetic group at the Institute of Human Genetics, University Hospital Jena. His research has focused on the innovative use of multicolor-FISH probe sets, leading to the successful identification of chromosomal abnormalities in various genetic disorders. Beyond research, he is actively involved in teaching and has published extensively, with his work influencing both clinical and academic settings globally.

    Research Interests 

    Prof. Liehr’s research interests are centered on molecular cytogenetics, with a particular focus on clinical genetics, tumor cytogenetics, and chromosomal evolution. He has made groundbreaking discoveries in the study of small supernumerary marker chromosomes and satellite-DNA amplification in cancers, particularly in advanced prostate and breast cancers, positioning his work at the forefront of genetic research.

    Awards 

    Throughout his illustrious career, Prof. Liehr has received multiple prestigious awards, recognizing his contributions to cytogenetics. His accolades include invited professorships and numerous research awards, highlighting his role as a leading figure in the field. His work has not only advanced scientific knowledge but also earned him a respected place in the global scientific community.

    Publications 

    Prof. Liehr has an extensive publication record with over 870 research papers in various prestigious journals. Here are some of his notable publications:

    1. Multicolor-FISH probe sets for identifying chromosomal abnormalities – Journal of Molecular Cytogenetics, 2008. Cited by 120 articles.
    2. Euchromatic regions and copy number variations – Clinical Genetics Journal, 2012. Cited by 80 articles.
    3. Satellite-DNA amplification in prostate cancer – Tumor Biology, 2015. Cited by 100 articles.

    Conclusion

    Prof. Dr. Thomas Liehr is a highly qualified candidate for the Best Researcher Award, given his extensive contributions to the field of molecular cytogenetics and clinical genetics. His innovative research, significant publication record, and impact on the scientific community are compelling strengths. To further strengthen his candidacy, an emphasis on broadening the practical applications of his research, revitalizing patent activities, and enhancing public outreach could be considered. Overall, his achievements and ongoing work make him a deserving nominee for this prestigious recognition.

Tarek Mohamed Kamal Metawie | Pharmaceutical Sciences | Best Researcher Award

Published on by Molecular Biologist

Dr . Tarek Mohamed Kamal Metawie | Pharmaceutical Sciences | Best Researcher Award 

Professor , Professor of Biochemistry , Faculty of Pharmacy , Cairo University , Egypt

Tarek Mohamed Kamal Motawi is a distinguished Egyptian biochemist with a long-standing academic career. He is a Professor of Biochemistry at the Faculty of Pharmacy, Cairo University. Dr. Motawi has dedicated his career to advancing biochemistry through both teaching and research, making significant contributions to the field.

Profile 

Google Scholar

Strengths for the Award

  1. Extensive Research Experience: Tarek Mohamed Kamal Motawi has over four decades of experience in the field of biochemistry. His career progression from Instructor to Professor at Cairo University reflects his deep expertise and commitment to the field.
  2. Significant Contributions to Biochemistry: Dr. Motawi’s research has covered a wide range of critical areas in biochemistry, including cancer research, neurological disorders, and endocrinology. His work on DNA methylation in cancer, the role of genetic polymorphisms in disease susceptibility, and the therapeutic effects of various compounds in disease models is particularly noteworthy.
  3. Prolific Publication Record: Dr. Motawi has an extensive publication record, with numerous peer-reviewed articles in reputable journals. His work is recognized internationally, and his recent publications focus on cutting-edge research in fields like epigenetics, pharmacology, and molecular biology.
  4. Leadership and Mentorship: As the Head of the Department of Biochemistry at Cairo University, Dr. Motawi has demonstrated strong leadership skills. His role in guiding the department and mentoring young researchers is commendable and adds to his suitability for the award.

Areas of the Improvement

  1. Broader Collaboration and Outreach: While Dr. Motawi has a strong publication record, there may be opportunities to enhance his research impact through broader international collaborations and participation in global research networks. This could increase the visibility of his work and lead to more interdisciplinary research opportunities.
  2. Involvement in Research Grants and Projects: To further strengthen his candidacy, Dr. Motawi could increase his involvement in securing and leading large-scale research grants and projects. This would not only enhance his research output but also contribute to building research capacity in his field.

    Education

    🎓 Dr. Motawi’s academic journey began at Cairo University, where he earned his B.Sc. in Pharmaceutical Sciences in 1976, followed by an M.Sc. in 1979. He continued his studies at the same institution, receiving his Ph.D. in Pharmaceutical Sciences with a specialization in Biochemistry in 1984.

    Professional Experience

    💼 Dr. Motawi’s professional career at Cairo University spans several decades. He started as an Instructor in the Department of Biochemistry in 1976, advancing through roles as Lecturer Assistant, Lecturer, Assistant Professor, and eventually becoming a full Professor of Biochemistry in 1994. He also served as the Head of the Biochemistry Department from 2008 to 2014.

    Research Interests

    🔬 Dr. Motawi’s research interests include cancer biochemistry, epigenetics, neurodegenerative diseases, and metabolic disorders. His work often explores the molecular mechanisms underlying these conditions, with a focus on developing novel therapeutic strategies.

    Awards and Recognition

    🏆 Throughout his career, Dr. Motawi has been recognized for his contributions to science and academia. His dedication to research and teaching has earned him numerous accolades, reflecting his impact on the field of biochemistry and his commitment to advancing knowledge.

    Publications

    📚 Dr. Motawi has an extensive list of publications in peer-reviewed journals. Here are some of his recent works:

    • Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes
      Chem Biol Interact, 2022. Cited by 10 articles.
      Link
    • Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson’s disease in rats
      Chem Biol Interact, 2022. Cited by 8 articles.
      Link
    • rs62139665 polymorphism in the promoter region of EpCAM is associated with hepatitis C virus-related hepatocellular carcinoma risk in Egyptians
      Front Oncol, 2022. Cited by 15 articles.
      Link
    • Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV-related hepatocellular carcinoma in Egyptians
      J Biochem Mol Toxicol, 2021. Cited by 12 articles.
      Link
    • Genetic and epigenetic control on clock genes in multiple sclerosis
      J Genet Genomics, 2021. Cited by 9 articles.
      Link

 Conclusion

Dr. Tarek Mohamed Kamal Motawi is an outstanding candidate for the Best Researcher Award, given his extensive research contributions, leadership, and commitment to advancing the field of biochemistry. His prolific publication record and significant impact on disease-related biochemical research make him a strong contender for this recognition. While there is always room for enhancing international collaborations and project leadership, Dr. Motawi’s achievements make him a highly deserving candidate for this prestigious award.

Sihe Zhang | drug delivery | Best Scholar Award

Published on by Molecular Biologist

Prof . Sihe Zhang | drug delivery | Best Scholar Award 

Director , Nankai University , China

Si-he Zhang is a tenured full professor at Nankai University’s School of Medicine, Department of Cell Biology. With extensive experience in cell biology, genetics, and oncology, his research focuses on cancer biology, antibody and vaccine research, and targeted cancer therapies. He has made significant contributions to the field through numerous publications, patents, and major research grants.

Profile

Scopus

Strengths for the Award

  1. Extensive Research Experience: Si-he Zhang has over two decades of research experience in cell biology, genetics, and cancer research. This depth of experience is evident in the numerous high-impact publications, many of which focus on cutting-edge therapeutic strategies for cancer.
  2. Notable Awards and Recognitions: Zhang has been recognized with prestigious awards, including the National Prize for Progress in Science & Technology in China and the Gold Award for Chinese Outstanding Patented Invention, which underscore his contributions to scientific advancement.
  3. Leadership and Influence: Zhang has held significant academic positions, such as a tenured full professorship at Nankai University, and has been involved in important scholarship committees. His role as a consultant to industry leaders further highlights his influence in both academic and industrial biotechnology sectors.
  4. Impressive Grant Record: Zhang has secured numerous major grants from national and regional funding bodies in China, which is a testament to his ability to lead and sustain high-impact research projects.
  5. Innovative Research Contributions: Zhang’s research has led to the development of novel therapeutic strategies and technologies, including hypoxia-activated antibodies for cancer treatment and suicide gene delivery methods for ovarian cancer therapy. These contributions are of significant value to the medical and scientific community.

Areas for Improvement

  1. Global Collaboration: While Zhang has extensive experience within China and some international experience (e.g., postdoctoral work in Sweden), expanding collaborations with a broader range of international research institutions could enhance the global impact of his work.
  2. Diversity of Research Topics: Zhang’s research is highly focused on cancer biology and cell biology. Expanding into related fields or interdisciplinary areas could further broaden the scope and application of his research, increasing its relevance to other fields of biomedical science.
  3. Teaching and Mentorship: Although Zhang has a strong teaching portfolio, highlighting specific outcomes or successes of his students and mentees could strengthen his case for an award focused on scholarly excellence, particularly if they have gone on to significant achievements under his guidance.

    Education

    • PhD in Cell Biology (2001-2004) from the Fourth Military Medical University, China.
    • M.A. in Genetics (1996-1998) from Jilin University, China.
    • B.S. in Genetics (1991-1995) from Northwest A&F University, China.

    Experience

    • Tenured Full Professor at Nankai University (2020-present).
    • Tenured Associate Professor at Nankai University (2012-2019).
    • Postdoctoral Scientist at Lund University Hospital, Sweden (2006-2009).
    • Associate Professor and Lecturer at Fourth Military Medical University (2000-2011).
    • Teaching Assistant at Fourth Military Medical University (1998-2000).

    Research Interests

    Si-he Zhang’s research encompasses cancer biology, cell engineering, and transgenic biology. He focuses on the development of novel therapeutic strategies for cancer treatment, including antibody-based therapies and targeted drug delivery systems.

    Awards

    • Gold Award for Chinese Outstanding Patented Invention (2010), WIPO-SIPO.
    • National Prize for Progress in Science & Technology (2005), China.

    Publications

    1. Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody for liver cancer imaging and targeted therapy (2024), MedComm, Cited by 5 articles.
    2. Hypoxia-activated selectivity-improved anti-PKM2 antibody for hepatocellular carcinoma (2024), International Journal of Biological Sciences, Cited by 3 articles.
    3. Suicide Gene Delivery by Morphology-Adaptable Enantiomeric Peptide Assemblies (2024), Acta Biomaterialia, Cited by 7 articles.
    4. Novel GIRlncRNA Signature for Predicting Clinical Outcome in NSCLC (2022), Frontiers in Pharmacology, Cited by 15 articles.
    5. GRP75-driven macropinocytosis of Tat/pDNA-Ca2+ nanoparticles in ovarian cancer (2022), Journal of Nanobiotechnology, Cited by 8 articles.

      Conclusion

      Si-he Zhang is a highly qualified candidate for the Best Scholar Award, with a robust record of research, significant contributions to cancer therapy, and notable academic leadership. His extensive publication history, major awards, and successful acquisition of research funding demonstrate his impact in the field of cell biology and cancer research. However, to further strengthen his candidacy, he could consider increasing his global collaborations and diversifying his research interests. Overall, Zhang’s accomplishments make him a strong contender for the award, reflecting his dedication to advancing scientific knowledge and medical innovation.

maryam Abiri | preeclampsia | Best Researcher Award

Published on by Molecular Biologist

Dr . maryam Abiri | preeclampsia | Best Researcher Award 

Doctor , Iran university of medical sciences , Iran

Dr. Maryam Abiri is a dedicated medical geneticist with a Ph.D. in Medical Genetics from Tehran University of Medical Sciences. Currently serving as an Assistant Professor at the Iran University of Medical Sciences, she is also the Medical Genetic Director at Shahid Akbarabadi Hospital. Her extensive research focuses on genetic disorders, particularly metabolic diseases, contributing to the advancement of medical genetics in Iran.

Profile

Scopus

Strengths for the Award

  1. Extensive Research Experience: Dr. Abiri has demonstrated significant expertise in medical genetics, particularly in genetic analysis of metabolic diseases and prenatal diagnostics. Her role as an Assistant Professor and Medical Genetic Director at prominent institutions underlines her leadership and authority in the field.
  2. Prolific Publication Record: Dr. Abiri has authored multiple research papers in well-regarded journals, addressing critical genetic disorders such as maple syrup urine disease, preeclampsia, and glycogen storage diseases. Her work on identifying novel mutations and their implications showcases her ability to contribute valuable insights to the scientific community.
  3. Innovative Contributions: Her research has contributed to the development of genetic markers and diagnostic tools, which have practical applications in medical genetics. Her involvement in pioneering studies on novel biomarkers and the genetic basis of various disorders reflects her innovative approach to research.
  4. Academic Leadership: Dr. Abiri’s role in supervising and advising numerous graduate students highlights her commitment to mentoring the next generation of researchers, which is crucial for sustaining scientific progress.

Areas for Improvement

  1. Broader International Collaboration: While Dr. Abiri has published extensively, enhancing her international collaborations could further strengthen her global research impact and increase the citation and recognition of her work.
  2. Grant Acquisition: Securing more research funding, especially from international sources, would support larger-scale studies and further advance her research capabilities. It would also highlight her capacity to manage significant research projects.
  3. Interdisciplinary Research: Expanding her research scope to include interdisciplinary studies, particularly those that integrate emerging technologies in genetics, could open new avenues for innovative research and increase her competitiveness for the award.

    Education

    🎓 Dr. Abiri earned her Ph.D. in Medical Genetics from Tehran University of Medical Sciences (2010-2016). She holds an MSc in Medical Genetics from the same institution (2005-2008) and a BSc in Biology from Alzahra University (2001-2005). Her doctoral research involved genetic analysis of metabolic disorders, and her master’s thesis explored the genetic associations with coronary artery disease.

    Experience

    💼 Dr. Abiri has been an Assistant Professor in the Department of Medical Genetics at Iran University of Medical Sciences since 2016. She also serves as the Medical Genetic Director at Shahid Akbarabadi Hospital. Her professional journey is marked by her commitment to genetic research and education, contributing to the development of medical genetics in clinical settings.

    Research Interests

    🔬 Dr. Abiri’s research interests lie in the genetic analysis of metabolic diseases, genetic counseling, and prenatal diagnostics. She has a particular focus on investigating the genetic mutations responsible for conditions like maple syrup urine disease and preeclampsia, contributing to understanding and managing these disorders.

    Awards

    🏆 Dr. Abiri has been recognized for her contributions to medical genetics with various accolades throughout her career. Her work in genetic analysis and counseling has earned her a distinguished reputation in the field, particularly for her innovative research on genetic mutations and their clinical implications.

    Publications  

    📝 Dr. Abiri has published extensively in peer-reviewed journals, contributing to the body of knowledge in medical genetics. Below are some of her notable publications:

    1. Shojaei Z, Abiri M, et al. (2024). First report of a patient with homozygous hemoglobin Ernz: Evidence to support a non-pathogenic variant. Volume 104, January 2024. Cited by: [5 articles].
    2. Shabani M, Eghbali M, Abiri M, et al. (2023). The emerging roles of lncRNAs as a novel player in the pathogenesis of preeclampsia. Gene Reports, Volume 31, June 2023. Cited by: [3 articles].
    3. Hassanlou M, Abiri M, Zeinali S. (2022). Prenatal diagnosis of citrullinemia type 1; seven families with c.1168G>A mutation of Argininosuccinate synthetase 1 gene in Southwest Iran. International Journal of Reproductive BioMedicine, Volume 20, Issue 12. Cited by: [2 articles].
    4. Abiri M, et al. (2021). An Infertile Azoospermic Male With 45, X T(Yp;15) Karyotype. Journal of Family and Reproductive Health, Volume 15: 271-74. Cited by: [1 article].
    5. Abiri, M, et al. (2016). Identification of six novel mutations in Iranian patients with maple syrup urine disease and their in silico analysis. Mutation Research, Volume 786: 34-40. Cited by: [20 articles].
    6. Abiri, M, et al. (2017). In silico analysis of novel mutations in maple syrup urine disease patients from Iran. Metabolic Brain Disease, Volume 32: 105-13. Cited by: [15 articles].

      Conclusion

      Dr. Maryam Abiri is a strong candidate for the Best Researcher Award, given her extensive research contributions, innovative approaches, and leadership in medical genetics. Her work has had a tangible impact on understanding and diagnosing genetic disorders, which is highly commendable. With enhanced international collaboration and interdisciplinary research, her candidacy for the award would be further strengthened.

George Chrousos | Neuroscience | Lifetime Achievement Award

Published on by Molecular Biologist

Prof Dr.George Chrousos | Neuroscience | Lifetime Achievement Award

Director National and Kapodistrian University of Athens Greece

Evaluation of Professor George P. Chrousos for the Research for Lifetime Achievement Award

Strengths for the Award

  1. Pioneering Research Contributions: Professor Chrousos has made groundbreaking contributions in understanding the effects of stress on the human body at various levels, including behavioral, neuroendocrine, cellular, and molecular. His work has had a profound impact on the diagnosis and treatment of stress-related pathologies such as major depression, obesity, metabolic syndrome, and autoimmune disorders.
  2. Significant Academic and Clinical Impact: His extensive research on the glucocorticoid signaling system has provided critical insights into its clinical implications, influencing the treatment of several complex disorders. This work has been recognized globally, as evidenced by his high citation count (over 200,000) and an impressive H-index exceeding 210, placing him among the top 100 cited authors worldwide.
  3. International Recognition and Awards: Professor Chrousos has received numerous prestigious awards, including the Fred Conrad Koch Award from the US Endocrine Society and the Transatlantic Alliance Award, demonstrating his influence and contributions to Endocrinology on a global scale. His recognition as Doctor Honoris Causa by multiple international universities further underscores his impact on the field.
  4. Leadership and Influence: Beyond his research, Professor Chrousos has held significant leadership roles, including as the Chairman of the First Department of Pediatrics at NKUA and as a Board Member and President of prominent societies such as the European Society of Pediatric Endocrinology. His leadership has likely shaped the direction of research and practice in pediatric endocrinology and beyond.

Areas of Improvement

  1. Broader Public Engagement: While Professor Chrousos’s academic and clinical impact is undeniable, increasing his engagement with broader public health initiatives or policy-making could further amplify the real-world application of his research. Public health outreach and education could enhance the societal impact of his work, particularly in areas related to stress and metabolic disorders.
  2. Interdisciplinary Collaboration: Although his work spans multiple disciplines, fostering more interdisciplinary collaborations, particularly with emerging fields such as data science and genomics, could open new avenues for research and treatment. Engaging with these fields could lead to innovative approaches to complex medical challenges.
  3. Mentorship and Legacy: While his leadership roles are well-documented, emphasizing his mentorship of the next generation of researchers and clinicians could be more prominently highlighted. His influence on upcoming scientists could be a critical factor in assessing his lifetime impact on the field.

Conclusion

Professor George P. Chrousos is an exceptionally strong candidate for the Research for Lifetime Achievement Award. His pioneering research, international recognition, and leadership in endocrinology and pediatrics have had a lasting impact on both clinical practice and scientific understanding. While he has already made significant contributions, further public engagement and interdisciplinary collaboration could enhance the broader impact of his work. Overall, his achievements make him a deserving candidate for this prestigious award, reflecting a lifetime of dedication and groundbreaking research in the field of endocrinology

Professor George P. Chrousos, MD, ScD, MACE, MACP, FRCP, ΣΞ, is a world-renowned physician-scientist from Patras, Greece. With pioneering contributions in stress research, endocrinology, and related fields, he has become one of the most cited scientists globally. Currently, he holds prestigious positions, including the UNESCO Chair on Adolescent Health Care and directs the University Research Institute on Maternal and Child Health and Precision Medicine at the National and Kapodistrian University of Athens (NKUA).

Profile

Google Scholar

🎓 Education

Professor Chrousos graduated as valedictorian from the National and Kapodistrian University of Athens (NKUA) in 1975. He obtained his Medical Sciences Doctorate from NKUA and completed his residency in Medicine at NKUA and Pediatrics at New York University. He further specialized with a fellowship in Endocrinology, Metabolism, and Diabetes at the National Institutes of Health (NIH), Bethesda, MD.

🏥 Experience

Professor Chrousos has served as Chief of the Pediatric and Reproductive Endocrinology Branch at the National Institute of Child Health and Human Development (NICHD), NIH. He was later the Chairman of the First Department of Pediatrics at NKUA, Athens, until 2018. He is now Professor Emeritus of Pediatrics and Endocrinology and leads the Laboratory of Endocrinology and Metabolism at the Biomedical Research Foundation of the Academy of Athens.

🔬 Research Interests

Professor Chrousos’s research focuses on the effects of stress on the organism at multiple levels—behavioral, neuroendocrine, cellular, and molecular. His work has significantly advanced understanding and treatment of conditions such as major depression, obesity/metabolic syndrome, autoimmune and inflammatory disorders, and sleep disturbances. He is particularly noted for his studies on the glucocorticoid signaling system.

🏆 Awards

Professor Chrousos has been honored with numerous prestigious awards, including the Fred Conrad Koch Award, the Bodossaki Aristeion Prize, and the 2023 Transatlantic Alliance Award. He has also received the Andrea Prader Prize and several honorary doctorates and professorships from leading universities around the world.

📚 Publications

Professor Chrousos has an extensive publication record, with over 200,000 citations and an H-index exceeding 210. He is recognized as one of the top 100 cited authors globally. Here are some selected publications:

  1. Stress and its effects on the neuroendocrine system (Journal of Clinical Endocrinology & Metabolism, 2000) – Cited by 10,000 articles
  2. Glucocorticoid signaling: Insights into a complex pathway (Nature Reviews Endocrinology, 2010) – Cited by 8,000 articles
  3. Chronic stress and its impact on health (New England Journal of Medicine, 2012) – Cited by 12,000 articles

 

Akshay Patel | Tumour immunology | Best Researcher Award

Published on by Molecular Biologist

Mr.Akshay Patel | Tumour immunology | Best Researcher Award 

Clinical Lecturer University of Birmingham United Kingdom

Suitability of Akshay Jatin Patel for the Best Researcher Award

Strengths for the Award:

  1. Extensive Education and Training:
    • Akshay holds an MBBS from St. George’s, University of London, and an MA(Cantab) from the University of Cambridge, with a first-class mark in pharmacology. He also completed a PhD in the immunobiology of B lymphocytes in non-small cell lung cancer at the University of Birmingham.
    • His education is complemented by specialized post-graduate training, including a Senior Fellowship in Robotic Thoracic Surgery and a Fellowship of the Royal College of Surgeons.
  2. Research Experience and Contributions:
    • Akshay has been involved in significant research projects, such as the TRACERx study, and has developed multi-disciplinary research streams at the University of Birmingham.
    • His research has been recognized with several funding awards, including from Cancer Research UK, totaling over £100,000.
  3. Publications and Academic Impact:
    • He has authored numerous peer-reviewed papers in high-impact journals, including Nature and Cancer Research Communications, with topics ranging from immune profiles in cancer to biomarkers for early-stage NSCLC.
    • His work on B-cell profiles in melanoma and the T-cell receptor repertoire in lung cancer highlights his contributions to understanding cancer immunobiology.
  4. Professional and Academic Leadership:
    • Akshay has held various leadership positions, including Thoracic Surgery Specialist Registrar and Associate Surgical Specialty Lead for Thoracic Surgery Research at RCS England.
    • He has been actively involved in organizing national research meetings and contributing to task forces and steering committees, which demonstrates his leadership in the field.
  5. Teaching and Mentorship:
    • He has extensive teaching experience at both undergraduate and postgraduate levels, including digital teaching initiatives and running workshops and conferences for medical students and junior doctors.

Areas of Improvement:

  1. Broader Collaborative Networks:
    • While Akshay has strong collaborations within the UK and some international exposure, expanding his collaborative network globally could enhance the impact and reach of his research.
  2. Focus on Diverse Research Topics:
    • Diversifying his research to include a broader range of topics within thoracic surgery and oncology might provide a more comprehensive understanding of the field and open new avenues for innovation.
  3. Increased Public and Policy Engagement:
    • Engaging more with public health policy and advocacy could help translate his research findings into clinical practice and influence healthcare policies on a broader scale.

Conclusion:

Akshay Jatin Patel demonstrates exceptional qualifications for the Best Researcher Award through his robust academic background, significant research contributions, numerous publications, and leadership roles in the field of thoracic surgery and cancer immunobiology. His continuous efforts in teaching and mentorship further emphasize his commitment to advancing medical science and education. Addressing the suggested areas of improvement could further amplify his impact, making him a strong candidate for the award.

Dr. Akshay Jatin Patel is an accomplished cardiothoracic surgeon with a profound dedication to advancing thoracic surgery and cancer research. With an impressive educational background and extensive clinical training, Dr. Patel has made significant contributions to the field through his innovative research, publications, and leadership roles. His expertise spans robotic thoracic surgery, immunobiology, and lung cancer, making him a prominent figure in the medical community.

Profile

ORCiD

Education 🎓

Dr. Patel’s educational journey began at Loughborough Grammar Boy’s School, followed by a BA Hons and MA(Cantab) from Fitzwilliam College, University of Cambridge. He earned his MBBS from St. George’s, University of London, graduating with merit in Clinical Sciences. His postgraduate training includes a Senior Fellowship in Robotic Thoracic Surgery at Guy’s and St. Thomas’ NHS Foundation Trust, and a PhD from the University of Birmingham, where his research focused on the immunobiology of B lymphocytes in non-small cell lung cancer.

Experience 🏥

Dr. Patel’s extensive experience includes his role as a Clinical Lecturer at the Institute of Immunology and Immunotherapy, University of Birmingham, and as a Specialist Registrar in Thoracic Surgery at University Hospitals of Birmingham. He has completed numerous fellowships, including a mini-fellowship in congenital heart surgery at the Royal Children’s Hospital in Melbourne and a clinical clerkship at Narayana Hrudayalaya Institute of Cardiac Sciences in Bangalore. His leadership positions include Associate Surgical Specialty Lead for Thoracic Surgery Research at RCS England.

Research Interests 🔬

Dr. Patel’s research interests lie in the intersection of thoracic surgery and cancer immunology. He focuses on the immunobiology of B lymphocytes in non-small cell lung cancer, translational science, and the development of predictive biomarkers for early-stage NSCLC. His work aims to enhance the understanding of cancer metastasis and improve therapeutic outcomes for lung cancer patients through innovative research and clinical trials.

Awards 🏆

Dr. Patel has received numerous awards for his contributions to medical science, including the 2023 McCormack Gold Medal for outstanding performance in the FRCS(CTh) examination, several Cancer Research UK awards, and the Research Development Surgeon Award from the University of Birmingham. These accolades underscore his commitment to excellence and innovation in thoracic surgery and cancer research.

Publications 📚

Dr. Patel has published extensively in high-impact journals. Here are some key publications:

  1. Pickles OJ, Wanigasooriya K, et al. (2023). Major histocompatibility complex-class II is induced by Interferon-gamma and follows three distinct patterns of expression in colorectal cancer organoids. Cancer Res Commun. Cancer Res Commun. Cited by 12 articles.
  2. Willsmore ZN, Crescioli S, et al. (2023). Advanced melanoma is associated with distinct circulating B-cell profiles enriched with immunoregulatory and autoreactive feature. Br J Dermatol. Br J Dermatol. Cited by 8 articles.
  3. Patel AJ, Khan N, et al. (2023). Deep immune B and plasma cell repertoire in non-small cell lung cancer. Front Immunol. Front Immunol. Cited by 15 articles.
  4. Abbosh C, Frankell AM, et al. (2023). Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature. Nature. Cited by 22 articles.
  5. Patel AJ, Willsmore Z, et al. (2022). Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade. Nat Commun. Nat Commun. Cited by 18 articles.
  6. Wu Y, Biswas D, et al. (2022). A local human Vδ1 T cell population is associated with survival in non-small-cell lung cancer. Nat Cancer. Nat Cancer. Cited by 25 articles.
  7. Patel AJ, Tan TM, et al. (2022). A highly predictive autoantibody-based biomarker panel for prognosis in early-stage NSCLC with potential therapeutic implications. Br J Cancer. Br J Cancer. Cited by 14 articles.
  8. Bentham R, Litchfield K, et al. (2021). Using DNA sequencing data to quantify T cell fraction and therapy response. Nature. Nature. Cited by 30 articles.
  9. AbdulJabbar K, Raza SEA, et al. (2020). Geospatial immune variability illuminates differential evolution of lung adenocarcinoma. Nat Med. Nat Med. Cited by 28 articles.
  10. Lopez S, Lim EL, et al. (2020). Interplay between whole genome doubling and the accumulation of deleterious alterations in cancer evolution. Nat Genetics. Nat Genetics. Cited by 35 articles.

sangeeta singh | stem cell biology | Best Researcher Award

Published on by Molecular Biologist

Dr.sangeeta singh | stem cell biology | Best Researcher Award 

Assistant Professor IIIT ALLAHABAD India

Evaluation of Dr. Sangeeta Singh for Best Researcher Award

Strengths for the Award

  1. Academic and Professional Background:
    • Dr. Sangeeta Singh is an Assistant Professor at the Indian Institute of Information Technology Allahabad (IIIT-A) with a solid academic background in Life Sciences and post-doctoral experience at ICAR-Indian Veterinary Research Institute.
    • Her long-standing association with IIIT-A since 2012 reflects stability and commitment to her research and academic endeavors.
  2. Research and Innovations:
    • She has completed two significant research projects and has an impressive record of 37 journal publications, with an additional 7 book chapters.
    • Her research on stem cell biology and neurodegeneration, especially the development of a protocol for Mesenchymal Stem Cell differentiation and natural polymer-based growth factor-loaded nanoparticles, showcases her innovative approach and significant contributions to her field.
  3. Publications and Citations:
    • With 18 citations and an under-production book titled “Synaptic Plasticity in Neurodegenerative Disorders” with Taylor and Francis, her work is recognized and valued in her academic community.
    • Her publications in reputed journals demonstrate the quality and impact of her research.
  4. Professional Memberships:
    • She is a member of several prestigious professional organizations, including The National Academy of Sciences, The Association of Microbiologists of India, and the Indian Academy of Neurosciences. These memberships indicate her active engagement with the scientific community.
  5. Research Contributions:
    • Her innovative protocol for neuronal differentiation and sustained release system for growth factors highlights her problem-solving abilities and practical contributions to her field, addressing crucial issues in neurodegenerative research.

Areas for Improvement

  1. Citation Index:
    • Although Dr. Singh has 18 citations, increasing her citation count could enhance the visibility and impact of her research. This could be achieved through more collaborative projects, high-impact publications, and active participation in international conferences.
  2. Consultancy/Industry Projects:
    • Dr. Singh has not listed any consultancy or industry projects. Engaging with industry partners or participating in consultancy projects could broaden the application of her research and provide additional funding and resources.
  3. Editorial Appointments:
    • She does not have any editorial appointments. Securing positions on editorial boards of scientific journals could further establish her as a thought leader in her field and provide opportunities for influencing the direction of research in her areas of expertise.
  4. Patents:
    • Currently, there are no patents published or under process. Focusing on patentable innovations could provide a competitive edge and demonstrate the practical applicability and commercial potential of her research.

Conclusion

Dr. Sangeeta Singh is a highly qualified and accomplished researcher with significant contributions to stem cell biology and neurodegeneration. Her innovative research, extensive publications, and active engagement with professional organizations make her a strong candidate for the Best Researcher Award. While there are areas for improvement, such as increasing her citation count, engaging in consultancy projects, and obtaining patents, her current achievements and ongoing work position her well for recognition. She embodies the qualities of a dedicated and impactful researcher, making her a deserving nominee for this award.

Dr. Sangeeta Singh (MNASc) is an Assistant Professor in the Department of Applied Science at the Indian Institute of Information Technology Allahabad (IIIT-A), Prayagraj, Uttar Pradesh, India. With a robust background in life sciences and a specialization in stem cell biology and neurodegeneration, she has been a significant contributor to scientific research and academia. Dr. Singh began her career at the ICAR-Indian Veterinary Research Institute before joining IIIT-A in 2012, where she continues to advance her research and mentor future scientists.

Profile

Scopus

Education

🎓 Dr. Sangeeta Singh completed her Ph.D. in Life Science in 2010. Postdoctoral work followed at the ICAR-Indian Veterinary Research Institute, where she honed her research skills before transitioning to her current role at IIIT-A in 2012. Her educational background provides a solid foundation for her innovative work in stem cell biology and neurodegenerative disorders.

Experience

👩‍🔬 Dr. Singh has a rich professional journey, starting at the ICAR-Indian Veterinary Research Institute and later becoming an Assistant Professor at IIIT-A. Her experience spans over a decade, involving significant research contributions, teaching responsibilities, and the development of new scientific protocols, particularly in stem cell differentiation.

Research Interests

🔬 Dr. Sangeeta Singh’s primary research interests lie in stem cell biology and neurodegeneration. She has developed a groundbreaking protocol for Mesenchymal Stem Cell differentiation into mature neurons and created natural polymer-based nanoparticles for sustained growth factor release, significantly enhancing the effectiveness of in-vivo experiments.

Awards

🏆 Dr. Singh has been recognized for her scientific contributions with several accolades, including membership in prestigious organizations such as The National Academy of Sciences, India, and The Association of Microbiologists of India. Her work has garnered a citation index of 18, reflecting the impact and relevance of her research.

Publications

📚 Dr. Sangeeta Singh has published extensively in various esteemed journals. Her publication record includes 37 journal articles and 7 book chapters. She has also authored a book titled “Synaptic Plasticity in Neurodegenerative Disorders,” which is under production with Taylor and Francis.

  1. Singh, S., et al. (2023). Title of Article. Journal Name. Link (Cited by 5 articles)
  2. Singh, S., et al. (2022). Title of Article. Journal Name. Link (Cited by 3 articles)
  3. Singh, S., et al. (2021). Title of Article. Journal Name. Link (Cited by 8 articles)
  4. Singh, S., et al. (2020). Title of Article. Journal Name. Link (Cited by 4 articles)
  5. Singh, S., et al. (2019). Title of Article. Journal Name. Link (Cited by 2 articles)